Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV.

Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS (2015) 0.80

Antiretroviral Resistance and Pregnancy Characteristics of Women with Perinatal and Nonperinatal HIV Infection. Infect Dis Obstet Gynecol (2016) 0.77

Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study. Eur J Clin Microbiol Infect Dis (2014) 0.77

Viral Suppression and Resistance in a Cohort of Perinatally-HIV Infected (PHIV+) Pregnant Women. Int J Environ Res Public Health (2016) 0.75

Pregnancy incidence and outcomes in women with perinatal HIV infection. AIDS (2017) 0.75

Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90

A United States national reference for fetal growth. Obstet Gynecol (1996) 13.21

The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med (1985) 12.23

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia (1993) 8.86

Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03

A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry (2010) 5.00

Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med (1999) 4.52

Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (1994) 2.67

Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr (2001) 2.26

Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. JAMA (2000) 2.25

US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks. Pediatrics (2003) 2.15

Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Clin Infect Dis (2011) 1.83

Long-term metabolic consequences of being born small for gestational age. Pediatr Diabetes (2004) 1.69

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics (2007) 1.64

Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53

Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors. Curr Opin Obstet Gynecol (2011) 1.42

Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis (2010) 1.39

Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium. Pediatr Infect Dis J (2001) 1.39

Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation. Pediatrics (1997) 1.31

Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol (2009) 1.15

The effect of parity on birthweight. J Obstet Gynaecol Br Commonw (1970) 1.14

Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants. AIDS (2010) 1.06

Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J Immunol (2008) 1.05

Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol (2008) 1.04

Birth outcomes in perinatally HIV-infected adolescents and young adults in Manipur, India: a new frontier. Arch Gynecol Obstet (2003) 1.03

Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. BMC Pediatr (2004) 1.01

Pregnancy outcomes in adolescents in the UK and Ireland growing up with HIV. HIV Med (2011) 0.99

Pregnancy outcomes in young women with perinatally acquired human immunodeficiency virus-1. Am J Obstet Gynecol (2008) 0.98

Pregnancy in women with perinatally acquired HIV-infection: outcomes and challenges. AIDS Care (2011) 0.96

Small for gestational age, term babies, in the first six years of life. Eur J Clin Nutr (1998) 0.93

Cocaine using during pregnancy and low birth weight: the impact of prenatal care and drug treatment. Semin Perinatol (1995) 0.93

Small for gestational age fetus and neonatal outcome: reevaluation of the relationship. Am J Perinatol (1995) 0.92

Neurodevelopmental outcome and school performance of very-low-birth-weight infants at 8 years of age. Eur J Pediatr (1986) 0.92

Successful pregnancy in an adolescent with perinatally acquired human immunodeficiency virus. Obstet Gynecol (1998) 0.92

Pregnancies in young women with vertically acquired HIV infection in Europe. AIDS (2007) 0.89

Insulin sensitivity in children born small for gestational age (SGA). Rev Diabet Stud (2004) 0.86

Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection. PLoS One (2011) 0.84

From the Center of Disease Control and Prevention. Pregnancy in perinatally HIV-infected adolescents and young adults--Puerto Rico, 2002. JAMA (2003) 0.80

Predictors of fetal growth in maternal HIV disease. Am J Perinatol (2010) 0.77

Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA (2007) 7.00

Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Intern Med (2003) 6.89

Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med (2010) 3.81

Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med (2010) 3.27

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med (2007) 2.93

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis (2009) 2.75

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA (2010) 2.67

Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry (2009) 2.57

Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. N Engl J Med (2012) 2.50

The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2004) 2.46

Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr (2009) 2.30

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. AIDS (2008) 2.14

Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC Pediatr (2010) 2.09

Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis (2010) 2.09

Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS (2013) 2.07

Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health (2010) 2.06

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis (2012) 2.05

Identification of iPhone and iPad applications for obstetrics and gynecology providers. Obstet Gynecol (2014) 2.04

A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel. PLoS One (2011) 2.00

Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis (2006) 1.93

Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? AIDS (2007) 1.91

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Clin Infect Dis (2008) 1.90

Sexual and drug use behavior in perinatally HIV-infected youth: mental health and family influences. J Am Acad Child Adolesc Psychiatry (2009) 1.88

Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Clin Infect Dis (2011) 1.83

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone). Am J Cardiol (2002) 1.81

Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative. Reprod Health Matters (2005) 1.77

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Am Heart J (2003) 1.74

Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arch Dis Child (2012) 1.73

Validation of a hepatitis C screening tool in primary care. Arch Intern Med (2008) 1.72

Family-centred approaches to the prevention of mother to child transmission of HIV. J Int AIDS Soc (2010) 1.67

Mother to child transmission of HIV in China. BMJ (2005) 1.66

Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration. Int J Epidemiol (2007) 1.60

Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr (2005) 1.59

Pulmonary Kaposi's sarcoma in pregnancy. Am J Perinatol (2004) 1.57

HIV as an independent risk factor for incident lung cancer. AIDS (2012) 1.54

Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg (2010) 1.54

Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review. AIDS (2014) 1.52

Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS (2009) 1.51

Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania. J Acquir Immune Defic Syndr (2013) 1.47

Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2015) 1.47

Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS One (2010) 1.46

Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med (2010) 1.43

HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine. AIDS (2011) 1.41

Inappropriate use of antibiotic prophylaxis to prevent infective endocarditis in obstetric patients. Obstet Gynecol (2006) 1.40

Impact of surveillance stool culture guided selection of antibiotics in the management of pediatric small bowel transplant recipients. Pediatr Transplant (2006) 1.39

The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS (2009) 1.38

Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. Pediatr Infect Dis J (2007) 1.38

Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J (2006) 1.37

Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol (2010) 1.37

CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr (2010) 1.35

Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age. Pediatr Infect Dis J (2005) 1.34

Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens. BMC Public Health (2010) 1.34

Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr (2011) 1.32

Treatment of young children with HIV infection: using evidence to inform policymakers. PLoS Med (2012) 1.32

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J (2006) 1.32

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31

Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health (2011) 1.30

Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis. J Acquir Immune Defic Syndr (2006) 1.27

Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol Biol (2006) 1.27

Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa. AIDS Res Hum Retroviruses (2011) 1.22

Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics (2009) 1.22

Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth. AIDS Care (2012) 1.21

Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries. J Acquir Immune Defic Syndr (2013) 1.20

Adverse event reporting in cancer clinical trial publications. J Clin Oncol (2013) 1.20

Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. AIDS (2010) 1.19

Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS (2009) 1.18

Boarder babies with AIDS in harlem: lessons in applied public health. Am J Public Health (2002) 1.17

Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol (2011) 1.16

Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity. Br J Haematol (2012) 1.14

The influence of pregnancy on systemic immunity. Immunol Res (2012) 1.14

Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J (2013) 1.12

Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children. Clin Infect Dis (2011) 1.10

Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS (2014) 1.10

Adapting a Family-Based HIV Prevention Program for HIV-Infected Preadolescents and Their Families: Youth, Families and Health Care Providers Coming Together to Address Complex Needs. Soc Work Ment Health (2007) 1.09

Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS (2008) 1.07

The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol (2003) 1.07

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes. J Infect Dis (2013) 1.07

Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis. AIDS (2014) 1.07

Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstet Gynecol (2005) 1.06

Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol (2007) 1.06

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial. Hum Vaccin Immunother (2014) 1.05

Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav (2013) 1.05

Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS (2004) 1.04

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS (2004) 1.02

Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC. Environ Mol Mutagen (2007) 1.01

Low rates of mother-to-child HIV transmission in a routine programmatic setting in Lilongwe, Malawi. PLoS One (2013) 1.00

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics (2003) 1.00

Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr (2013) 1.00

HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children. Patient Educ Couns (2005) 0.99

Changes in the soluble mucosal immune environment during genital herpes outbreaks. J Acquir Immune Defic Syndr (2012) 0.98

Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol (2009) 0.97

Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression. AIDS (2004) 0.97

Racial disparities in the treatment of advanced epithelial ovarian cancer. Obstet Gynecol (2013) 0.97

High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010. Pediatr Infect Dis J (2013) 0.96

Rationale, design, and implementation protocol of an electronic health record integrated clinical prediction rule (iCPR) randomized trial in primary care. Implement Sci (2011) 0.96

Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed. AIDS (2015) 0.96

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Clin Infect Dis (2005) 0.95

Brief report: language ability and school functioning of youth perinatally infected with HIV. J Pediatr Health Care (2008) 0.94

Factor structure and longitudinal invariance of the Medical Adherence Report Scale-Asthma. Psychol Health (2011) 0.94

Longitudinal changes in regional fat content in HIV-infected children and adolescents. AIDS (2009) 0.94